标题:Betulinic acid increases radiosensitization of oral squamous cell carcinoma through inducing Sp1 sumoylation and PTEN expression
作者:Yuan, Dao-Ying; Meng, Zhen; Xu, Kai; Li, Qiao-Feng; Chen, Cheng; Li, Ke-Yi; Zhang, Bin
作者机构:[Yuan, Dao-Ying; Zhang, Bin] Shandong Univ, Sch Stomatol, Jinan, Shandong, Peoples R China.; [Yuan, Dao-Ying; Meng, Zhen; Xu, Kai; Li, Qiao-Feng; Ch 更多
通讯作者:Li, KY;Zhang, B
通讯作者地址:[Li, KY; Zhang, B]Liaocheng Peoples Hosp, Dept Oral & Maxillofacial Surg, 67 Dongchangxi Rd, Liaocheng 252000, Shandong, Peoples R China.
来源:ONCOLOGY REPORTS
出版年:2017
卷:38
期:4
页码:2360-2368
DOI:10.3892/or.2017.5872
关键词:radiation; betulinic acid; sumoylation; Sp1; PTEN; oral squamous cell; carcinoma
摘要:Radiotherapy is one of the most effective nonsurgical treatments for oral squamous cell carcinoma. However, radioresistance remains a major impediment to radiotherapy. Although BetA (Betulinic acid) can induce radiosensitization, the underlying mechanism and whether it could induce radiosensitization in oral squamous cell carcinoma are not fully understood. In this study, we showed that BetA increased radiosensitization in CAL-27 and Tca-83 cells. Radiation-triggered Sp1 overexpression was responsible for radioresistance of OSCC (oral squamous cell carcinoma) cells. Treatment with BetA downregulated Sp1 and upregulated PTEN through inducing Sp1 sumoylation and correspondingly increased radiosensitization. Moreover, Sumoylation of Sp1 upregulated PTEN protein expression by downregulating Sp1 as well as inhibiting Sp1 DNA binding activity, thereby leading to the activation of PTEN transcription. Our results suggested that BetA was able to enhance radiosensitization at least partially by downregulating Sp1 and upregulating PTEN through inducing Sp1 sumoylation. BetA is suggested to be a promising drug for increasing radiosensitization in oral squamous cell carcinoma radiotherapy.
收录类别:SCOPUS;SCIE
WOS核心被引频次:1
Scopus被引频次:1
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029807266&doi=10.3892%2for.2017.5872&partnerID=40&md5=aeaf576d64706eb0c9d8b9d7ad7e3440
TOP